1. Home
  2. DTIL vs BNTC Comparison

DTIL vs BNTC Comparison

Compare DTIL & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$7.35

Market Cap

362.6M

Sector

Health Care

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

315.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTIL
BNTC
Founded
2006
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.6M
315.4M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
DTIL
BNTC
Price
$7.35
$7.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
★ $29.40
$23.75
AVG Volume (30 Days)
★ 402.8K
154.2K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
N/A
★ N/A
Revenue
★ $1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$7.89
52 Week High
$11.29
$14.39

Technical Indicators

Market Signals
Indicator
DTIL
BNTC
Relative Strength Index (RSI) 48.99 37.62
Support Level $6.12 N/A
Resistance Level $7.80 $13.87
Average True Range (ATR) 0.93 0.66
MACD -0.22 -0.08
Stochastic Oscillator 17.63 5.18

Price Performance

Historical Comparison
DTIL
BNTC

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: